|
|
Vaccine Detail
|
anti-idiotypic (anti-id) mAb MK2-23 + BCG |
| Vaccine Information |
- Vaccine Name: anti-idiotypic (anti-id) mAb MK2-23 + BCG
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007264
- Type: Anti-idiotypic vaccine
- Status: Research
- Antigen: (HMW-MAA) mAb 763.74.
- Immunization Route: Intramuscular injection (i.m.)
- Description: There has been research using this vaccine to modulate immunogenicity in melanoma. (Mittelman et al., 1995)
|
| Host Response |
|
Mouse Response
- Vaccine Immune Response Type: VO_0003057
|
| References |
Mittelman et al., 1995: Mittelman A, Chen GZ, Wong GY, Liu C, Hirai S, Ferrone S. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1995; 1(7); 705-713. [PubMed: 9816036].
|
|
